Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Repressor Proteins | 7 | 2022 | 403 | 2.940 |
Why?
|
Homeodomain Proteins | 7 | 2022 | 535 | 2.790 |
Why?
|
Hematopoietic Stem Cells | 5 | 2023 | 292 | 2.230 |
Why?
|
Chromosomes, Human, Pair 7 | 5 | 2022 | 79 | 2.110 |
Why?
|
Nuclear Proteins | 6 | 2021 | 694 | 1.930 |
Why?
|
Leukemia, Myeloid, Acute | 7 | 2023 | 755 | 1.660 |
Why?
|
Neoplasms, Second Primary | 4 | 2022 | 252 | 1.530 |
Why?
|
Haploinsufficiency | 5 | 2023 | 62 | 1.510 |
Why?
|
Killer Cells, Natural | 8 | 2006 | 267 | 1.350 |
Why?
|
Chromosome Deletion | 4 | 2022 | 228 | 1.130 |
Why?
|
Transcription Factors | 9 | 2023 | 1555 | 1.120 |
Why?
|
Myelodysplastic Syndromes | 3 | 2018 | 345 | 1.090 |
Why?
|
Receptors, Immunologic | 7 | 2006 | 135 | 1.010 |
Why?
|
Hematopoiesis | 3 | 2018 | 163 | 0.900 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 262 | 0.830 |
Why?
|
Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2022 | 22 | 0.830 |
Why?
|
Chromosomes, Mammalian | 1 | 2021 | 36 | 0.820 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2021 | 29 | 0.810 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2021 | 90 | 0.790 |
Why?
|
Neoplasms | 7 | 2023 | 2889 | 0.750 |
Why?
|
Neoplasm Proteins | 2 | 2021 | 532 | 0.740 |
Why?
|
Myeloproliferative Disorders | 1 | 2022 | 109 | 0.740 |
Why?
|
DNA Repair | 1 | 2021 | 356 | 0.690 |
Why?
|
Genomics | 3 | 2022 | 710 | 0.670 |
Why?
|
Mice | 20 | 2023 | 11313 | 0.650 |
Why?
|
Antigens, CD | 6 | 2005 | 457 | 0.630 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 476 | 0.630 |
Why?
|
Gene Dosage | 1 | 2018 | 207 | 0.610 |
Why?
|
Membrane Glycoproteins | 5 | 2005 | 428 | 0.600 |
Why?
|
Transcription, Genetic | 2 | 2022 | 1135 | 0.580 |
Why?
|
Leukemia, Myeloid | 2 | 2020 | 249 | 0.570 |
Why?
|
Gene-Environment Interaction | 1 | 2017 | 103 | 0.570 |
Why?
|
Chromosome Aberrations | 1 | 2017 | 386 | 0.550 |
Why?
|
Self Tolerance | 2 | 2005 | 24 | 0.530 |
Why?
|
Enhancer Elements, Genetic | 1 | 2017 | 266 | 0.520 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 937 | 0.480 |
Why?
|
K562 Cells | 3 | 2022 | 43 | 0.480 |
Why?
|
Animals | 21 | 2023 | 26518 | 0.460 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 878 | 0.410 |
Why?
|
Erythrocyte Transfusion | 1 | 2010 | 60 | 0.350 |
Why?
|
CD2 Antigens | 2 | 2006 | 22 | 0.350 |
Why?
|
Isoantibodies | 1 | 2010 | 114 | 0.340 |
Why?
|
Humans | 28 | 2023 | 86281 | 0.340 |
Why?
|
Autoantibodies | 1 | 2010 | 267 | 0.340 |
Why?
|
Transcriptional Activation | 2 | 2022 | 280 | 0.330 |
Why?
|
U937 Cells | 2 | 2022 | 32 | 0.330 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2020 | 138 | 0.320 |
Why?
|
Anemia, Sickle Cell | 1 | 2010 | 131 | 0.320 |
Why?
|
Mutation | 6 | 2023 | 3952 | 0.300 |
Why?
|
Lymphocyte Subsets | 1 | 2006 | 64 | 0.280 |
Why?
|
Graft Rejection | 3 | 2006 | 1064 | 0.270 |
Why?
|
Genes, Tumor Suppressor | 3 | 2022 | 157 | 0.260 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2006 | 556 | 0.250 |
Why?
|
MCF-7 Cells | 2 | 2022 | 106 | 0.240 |
Why?
|
NIH 3T3 Cells | 2 | 2022 | 105 | 0.240 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 455 | 0.240 |
Why?
|
Immune Tolerance | 1 | 2006 | 337 | 0.230 |
Why?
|
Protein Isoforms | 2 | 2022 | 269 | 0.230 |
Why?
|
Cell Death | 2 | 2021 | 256 | 0.220 |
Why?
|
HL-60 Cells | 1 | 2022 | 20 | 0.210 |
Why?
|
Transcription Initiation Site | 1 | 2022 | 45 | 0.210 |
Why?
|
Gene Editing | 1 | 2022 | 42 | 0.210 |
Why?
|
Tumor Suppressor Proteins | 2 | 2014 | 279 | 0.200 |
Why?
|
Bridged Bicyclo Compounds, Heterocyclic | 1 | 2021 | 76 | 0.200 |
Why?
|
Gene Regulatory Networks | 1 | 2023 | 291 | 0.200 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2022 | 105 | 0.190 |
Why?
|
Heart Transplantation | 1 | 2006 | 705 | 0.190 |
Why?
|
Mice, Knockout | 6 | 2015 | 1918 | 0.180 |
Why?
|
Mitoxantrone | 1 | 2020 | 68 | 0.180 |
Why?
|
Signaling Lymphocytic Activation Molecule Family | 5 | 2005 | 15 | 0.180 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2005 | 203 | 0.180 |
Why?
|
Sulfonamides | 1 | 2021 | 299 | 0.180 |
Why?
|
Mice, Transgenic | 2 | 2021 | 1537 | 0.180 |
Why?
|
Stem Cells | 1 | 2022 | 350 | 0.180 |
Why?
|
Protein Phosphatase 2C | 1 | 2018 | 3 | 0.170 |
Why?
|
Cell Proliferation | 3 | 2018 | 1571 | 0.170 |
Why?
|
Bone Marrow | 1 | 2020 | 434 | 0.170 |
Why?
|
Genes, Neoplasm | 2 | 2016 | 37 | 0.170 |
Why?
|
Database Management Systems | 1 | 2018 | 41 | 0.160 |
Why?
|
Pathology, Molecular | 1 | 2018 | 34 | 0.160 |
Why?
|
Cell Line, Tumor | 5 | 2021 | 2421 | 0.160 |
Why?
|
Medical Informatics | 1 | 2018 | 47 | 0.160 |
Why?
|
Cellular Senescence | 1 | 2018 | 94 | 0.150 |
Why?
|
Consensus Sequence | 1 | 2017 | 64 | 0.150 |
Why?
|
Hep G2 Cells | 1 | 2017 | 48 | 0.150 |
Why?
|
Radiation Exposure | 1 | 2017 | 24 | 0.150 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 234 | 0.150 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2017 | 108 | 0.150 |
Why?
|
Clone Cells | 1 | 2017 | 213 | 0.150 |
Why?
|
Inflammation | 2 | 2022 | 913 | 0.150 |
Why?
|
Anemia | 1 | 2018 | 128 | 0.150 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2017 | 58 | 0.150 |
Why?
|
Bone Marrow Cells | 1 | 2017 | 253 | 0.140 |
Why?
|
Disease Models, Animal | 2 | 2018 | 2227 | 0.140 |
Why?
|
Peptide Termination Factors | 1 | 2016 | 5 | 0.140 |
Why?
|
Nucleic Acid Conformation | 1 | 2017 | 332 | 0.140 |
Why?
|
Retroviridae | 1 | 2016 | 78 | 0.140 |
Why?
|
Mutagenesis, Insertional | 1 | 2016 | 111 | 0.130 |
Why?
|
Risk Factors | 2 | 2017 | 5397 | 0.130 |
Why?
|
Wnt Signaling Pathway | 1 | 2016 | 89 | 0.130 |
Why?
|
RNA Interference | 2 | 2014 | 368 | 0.130 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 526 | 0.130 |
Why?
|
Cell Survival | 1 | 2017 | 966 | 0.130 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2017 | 136 | 0.130 |
Why?
|
Prognosis | 3 | 2017 | 3669 | 0.130 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 388 | 0.130 |
Why?
|
Major Histocompatibility Complex | 2 | 2005 | 81 | 0.120 |
Why?
|
Epistasis, Genetic | 1 | 2014 | 86 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 153 | 0.120 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2014 | 41 | 0.120 |
Why?
|
Mice, SCID | 2 | 2012 | 252 | 0.120 |
Why?
|
Mice, Inbred C57BL | 6 | 2015 | 3087 | 0.120 |
Why?
|
Computer Systems | 1 | 2014 | 79 | 0.120 |
Why?
|
Datasets as Topic | 1 | 2014 | 71 | 0.120 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2016 | 378 | 0.120 |
Why?
|
Hematopoietic System | 1 | 2013 | 13 | 0.120 |
Why?
|
CD48 Antigen | 4 | 2005 | 11 | 0.120 |
Why?
|
Protein Binding | 1 | 2017 | 1454 | 0.120 |
Why?
|
Gene Expression Profiling | 3 | 2017 | 1381 | 0.110 |
Why?
|
Base Sequence | 1 | 2017 | 2329 | 0.110 |
Why?
|
Carcinogenesis | 1 | 2015 | 194 | 0.110 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2012 | 12 | 0.110 |
Why?
|
Genes, ras | 1 | 2013 | 96 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 2267 | 0.110 |
Why?
|
GTP Phosphohydrolases | 1 | 2013 | 71 | 0.110 |
Why?
|
Mice, Inbred NOD | 1 | 2012 | 187 | 0.110 |
Why?
|
DNA Damage | 1 | 2014 | 362 | 0.110 |
Why?
|
Breast Neoplasms | 2 | 2017 | 2881 | 0.110 |
Why?
|
Nerve Tissue Proteins | 1 | 2015 | 503 | 0.100 |
Why?
|
RNA, Viral | 1 | 2013 | 327 | 0.100 |
Why?
|
Translocation, Genetic | 1 | 2012 | 265 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 1196 | 0.100 |
Why?
|
HeLa Cells | 1 | 2012 | 498 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2012 | 458 | 0.100 |
Why?
|
Blotting, Western | 1 | 2012 | 781 | 0.100 |
Why?
|
Mouth Neoplasms | 1 | 2013 | 194 | 0.100 |
Why?
|
Acute Disease | 1 | 2012 | 824 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 427 | 0.100 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 877 | 0.100 |
Why?
|
RNA | 1 | 2014 | 560 | 0.090 |
Why?
|
Laryngeal Edema | 1 | 2010 | 7 | 0.090 |
Why?
|
Hemagglutinins | 1 | 2010 | 19 | 0.090 |
Why?
|
Proteins | 1 | 2016 | 777 | 0.090 |
Why?
|
Acute Chest Syndrome | 1 | 2010 | 16 | 0.090 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 2351 | 0.090 |
Why?
|
Death, Sudden | 1 | 2010 | 40 | 0.090 |
Why?
|
Immunization | 1 | 2010 | 158 | 0.090 |
Why?
|
Software | 1 | 2014 | 650 | 0.090 |
Why?
|
Fatal Outcome | 1 | 2010 | 293 | 0.090 |
Why?
|
Herpes Simplex | 1 | 2010 | 202 | 0.080 |
Why?
|
Drosophila melanogaster | 1 | 2012 | 596 | 0.080 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2005 | 213 | 0.080 |
Why?
|
Signal Transduction | 3 | 2013 | 3233 | 0.080 |
Why?
|
Membrane Proteins | 1 | 2013 | 1194 | 0.070 |
Why?
|
Mice, Inbred BALB C | 2 | 2006 | 1047 | 0.070 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2006 | 20 | 0.070 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2006 | 29 | 0.070 |
Why?
|
Antigens, Ly | 1 | 2006 | 37 | 0.070 |
Why?
|
Genes, MHC Class I | 1 | 2006 | 48 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2010 | 1562 | 0.070 |
Why?
|
Sialic Acids | 1 | 2005 | 18 | 0.070 |
Why?
|
Transplantation, Isogeneic | 1 | 2005 | 39 | 0.070 |
Why?
|
Receptors, Antigen | 1 | 2005 | 11 | 0.070 |
Why?
|
beta 2-Microglobulin | 1 | 2005 | 24 | 0.070 |
Why?
|
Lymphoproliferative Disorders | 1 | 2006 | 107 | 0.070 |
Why?
|
Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2005 | 4 | 0.070 |
Why?
|
Lymphocyte Activation | 2 | 2005 | 727 | 0.070 |
Why?
|
Lectins | 1 | 2005 | 84 | 0.060 |
Why?
|
Pneumonia, Viral | 1 | 2010 | 316 | 0.060 |
Why?
|
Calcium Signaling | 1 | 2005 | 129 | 0.060 |
Why?
|
Cell Adhesion Molecules | 1 | 2005 | 163 | 0.060 |
Why?
|
Melanoma, Experimental | 1 | 2005 | 103 | 0.060 |
Why?
|
Immunoglobulins | 1 | 2005 | 148 | 0.060 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 285 | 0.060 |
Why?
|
Autoimmunity | 1 | 2005 | 160 | 0.060 |
Why?
|
Glycoproteins | 1 | 2005 | 234 | 0.060 |
Why?
|
Transplantation, Homologous | 1 | 2006 | 996 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2005 | 286 | 0.060 |
Why?
|
Antigens, Neoplasm | 1 | 2005 | 324 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2006 | 425 | 0.060 |
Why?
|
Child, Preschool | 1 | 2010 | 3608 | 0.060 |
Why?
|
Ethylnitrosourea | 1 | 2022 | 30 | 0.060 |
Why?
|
Early Growth Response Protein 1 | 1 | 2022 | 54 | 0.050 |
Why?
|
Antigens, CD34 | 1 | 2022 | 158 | 0.050 |
Why?
|
CD40 Ligand | 1 | 2000 | 69 | 0.050 |
Why?
|
Genes, p53 | 1 | 2020 | 109 | 0.050 |
Why?
|
Germ-Line Mutation | 1 | 2022 | 329 | 0.050 |
Why?
|
Immunoconjugates | 1 | 2000 | 106 | 0.050 |
Why?
|
MAP Kinase Signaling System | 1 | 2000 | 192 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 222 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2017 | 1975 | 0.040 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2000 | 165 | 0.040 |
Why?
|
Stromal Cells | 1 | 2020 | 142 | 0.040 |
Why?
|
Cytarabine | 1 | 2020 | 218 | 0.040 |
Why?
|
Azacitidine | 1 | 2020 | 137 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2005 | 813 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2000 | 206 | 0.040 |
Why?
|
Aged | 3 | 2022 | 18353 | 0.040 |
Why?
|
Genetic Testing | 1 | 2022 | 535 | 0.040 |
Why?
|
Remission Induction | 1 | 2020 | 722 | 0.040 |
Why?
|
Phenotype | 2 | 2014 | 2375 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2000 | 645 | 0.040 |
Why?
|
Male | 5 | 2014 | 40860 | 0.040 |
Why?
|
Limit of Detection | 1 | 2016 | 20 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2017 | 92 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 415 | 0.040 |
Why?
|
Gene Fusion | 1 | 2016 | 38 | 0.040 |
Why?
|
Benchmarking | 1 | 2016 | 78 | 0.040 |
Why?
|
Reference Standards | 1 | 2016 | 159 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2017 | 144 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2016 | 229 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2017 | 201 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 171 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 217 | 0.030 |
Why?
|
Apoptosis | 1 | 2021 | 1678 | 0.030 |
Why?
|
Alkylation | 1 | 2014 | 31 | 0.030 |
Why?
|
Gene Frequency | 1 | 2016 | 676 | 0.030 |
Why?
|
Female | 6 | 2017 | 44405 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2000 | 1195 | 0.030 |
Why?
|
Radiation, Ionizing | 1 | 2014 | 121 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2016 | 1208 | 0.030 |
Why?
|
Systems Integration | 1 | 2014 | 35 | 0.030 |
Why?
|
Myeloid Progenitor Cells | 1 | 2013 | 15 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2015 | 276 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2013 | 41 | 0.030 |
Why?
|
Heterozygote | 1 | 2014 | 365 | 0.030 |
Why?
|
Mice, Nude | 1 | 2015 | 790 | 0.030 |
Why?
|
Down-Regulation | 1 | 2014 | 504 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2014 | 1040 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2013 | 114 | 0.030 |
Why?
|
Interleukin-2 | 2 | 2005 | 249 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2013 | 153 | 0.030 |
Why?
|
Genome, Human | 1 | 2017 | 756 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 1987 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2018 | 2699 | 0.030 |
Why?
|
Internet | 1 | 2014 | 309 | 0.030 |
Why?
|
Cohort Studies | 1 | 2017 | 2759 | 0.020 |
Why?
|
Survival Analysis | 1 | 2013 | 1536 | 0.020 |
Why?
|
Adult | 3 | 2017 | 25577 | 0.020 |
Why?
|
Cell Line | 2 | 2005 | 2466 | 0.020 |
Why?
|
DNA Methylation | 1 | 2011 | 622 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2017 | 6481 | 0.020 |
Why?
|
CD4-CD8 Ratio | 1 | 2005 | 18 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 2005 | 57 | 0.020 |
Why?
|
Gene Targeting | 1 | 2005 | 72 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2005 | 171 | 0.020 |
Why?
|
Algorithms | 1 | 2013 | 1828 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2011 | 1611 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2005 | 444 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 895 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2005 | 319 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 2350 | 0.010 |
Why?
|
Middle Aged | 2 | 2017 | 24957 | 0.010 |
Why?
|
Calcineurin | 1 | 2000 | 16 | 0.010 |
Why?
|
NFATC Transcription Factors | 1 | 2000 | 29 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2000 | 36 | 0.010 |
Why?
|
Abatacept | 1 | 2000 | 83 | 0.010 |
Why?
|
Clonal Anergy | 1 | 2000 | 30 | 0.010 |
Why?
|
Tyrosine | 1 | 2000 | 133 | 0.010 |
Why?
|
CD28 Antigens | 1 | 2000 | 88 | 0.010 |
Why?
|
CTLA-4 Antigen | 1 | 2000 | 135 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2000 | 141 | 0.010 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2000 | 132 | 0.010 |
Why?
|
Immunologic Memory | 1 | 2000 | 152 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2000 | 692 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2000 | 371 | 0.010 |
Why?
|
Phosphorylation | 1 | 2000 | 1101 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2000 | 405 | 0.010 |
Why?
|
Adolescent | 1 | 2000 | 8968 | 0.000 |
Why?
|